Working… Menu

Bevacizumab in Severe or Critically Severe Patients With COVID-19 Pneumonia-RCT (BEST-RCT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04305106
Recruitment Status : Recruiting
First Posted : March 12, 2020
Last Update Posted : March 26, 2020
Renmin Hospital of Wuhan University
Ialy Moriggia Pelascini Gravedona Hospital S.p.A
Wuhan University
Jiangbei Union Hospital of Huazhong University of science and technology
Shandong Provincial Chest Hospital
Information provided by (Responsible Party):
Qilu Hospital of Shandong University

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 30, 2020
Estimated Study Completion Date : July 31, 2020